A LEADING MEDICAL RESEARCH INSTITUTE SPECIALISING IN ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
Alzheimer’s Research Australia
With Professor Vicky Vass, Chief Executive Officer
ORGANISATIONS IN MEDICAL RESEARCH
Filmed in Perth, Western Australia | November 2024
Professor Vicky Vass serves as the Chief Executive Officer of Alzheimer’s Research Australia, which is based in Perth, Western Australia. Australian Health Journal met with Professor Vass to hear of the organisation’s mission to solve the mysteries surrounding Alzheimer’s disease, and focus on detection as the key to their efforts.
Founded in 1993, the organisation now comprises a large research team, a clinical trials division, and an administrative support team. Their aim is to make Alzheimer’s a distant memory through rigorous research.
Their philosophy revolves around operating as one cohesive team, which includes all these parts as well as the board, fostering effective collaboration. Leading this team is Professor Ralph Martins AO, as the Chief Inspector in their mission. He focuses on uncovering pathways for prevention, intervention, and the latest treatments for neurodegenerative diseases.
Among the key studies highlighted by Professor Vass is the blood biomarker study led by Professor Ralph Martins, which aims to develop a cost-effective method for detecting Alzheimer’s through a simple blood test. Currently, detection methods involve multiple scans and intense processes, but this initiative could transform the landscape by making detection more accessible and affordable.
Another study is run by Dr. Prashant Bharadwaj who heads the research on childhood dementia, focusing on providing hope to the youngest patients affected by these debilitating diseases. His work is dedicated to ensuring that children have a future filled with memories rather than loss, striving to find ways to detect and ultimately cure childhood dementia.
The board of Alzheimer’s Research Australia comprises a diverse group of individuals, including academics and those involved in commercial work and aged care. The common goal uniting them is to find a cure for Alzheimer’s disease. Funding for the organisation primarily comes from donations and rely heavily on this support, as they do not receive significant government funding, although they do get some grants for research.
Professor Vass describes Alzheimer’s Research Australia as an incredible place to work, boasting a community akin to a family. Every role within the organisation is respected, contributing to a common goal of making Alzheimer’s a distant memory for future generations.
You Might also like
-
Budget22 A mixed dose of health outcomes
Australian Health Journal met with a number of industry heads after the budget on their journeys so far in lobbying for change, their achievements, some of the disappointments and their thoughts on the road ahead, with an election round the corner.
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.
-
Priming Australia for social prescribing
Social prescribing provides support in various areas of people’s lives, leading to increased confidence, improved navigation of systems, and enhanced friendships and trust in healthcare, while communities should be designed in an age-friendly way to prevent isolation.
In Part 1 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people advocating for social prescribing in Australia